症状性颈动脉狭窄-话题@MedSci - 梅斯（MedSci）

#症状性颈动脉狭窄#

10篇内容 | 1129人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2032664, encodeId=f74520326646a, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=Stroke：症状性颈动脉狭窄患者血小板粘附抑制剂Revacept的疗效, objectType=article, longId=729284, objectId=02a9e29284cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02a9e29284cb, replyNumber=0, likeNumber=83, createdTime=2022-06-29, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02a9e29284cb, moduleTitle=Stroke：症状性颈动脉狭窄患者血小板粘附抑制剂Revacept的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=02a9e29284cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032663, encodeId=dd23203266329, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=Stroke：颈动脉内膜切除术治疗症状性颈动脉狭窄不同分流模式的结局差异, objectType=article, longId=301658, objectId=87d7301658b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87d7301658b9, replyNumber=0, likeNumber=83, createdTime=2022-04-04, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87d7301658b9, moduleTitle=Stroke：颈动脉内膜切除术治疗症状性颈动脉狭窄不同分流模式的结局差异, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=87d7301658b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032662, encodeId=0eda20326624c, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=Stroke：症状性颈动脉狭窄，颈动脉内膜切除术仍然是早期治疗更安全的血管重建方法！, objectType=article, longId=221708, objectId=b803221e0841, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b803221e0841, replyNumber=0, likeNumber=73, createdTime=2021-12-27, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b803221e0841, moduleTitle=Stroke：症状性颈动脉狭窄，颈动脉内膜切除术仍然是早期治疗更安全的血管重建方法！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b803221e0841)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032661, encodeId=38712032661be, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=ATVB：软骨寡聚基质蛋白新表位是症状性颈动脉狭窄的新型生物标志物, objectType=article, longId=206151, objectId=c2e7206151f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2e7206151f1, replyNumber=0, likeNumber=93, createdTime=2021-06-28, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2e7206151f1, moduleTitle=ATVB：软骨寡聚基质蛋白新表位是症状性颈动脉狭窄的新型生物标志物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c2e7206151f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032660, encodeId=12fc20326607d, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=JAHA：症状性颈动脉狭窄颈动脉支架置入时机与卒中或死亡风险相关！, objectType=article, longId=133688, objectId=0ea41336883a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ea41336883a, replyNumber=0, likeNumber=88, createdTime=2018-08-07, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ea41336883a, moduleTitle=JAHA：症状性颈动脉狭窄颈动脉支架置入时机与卒中或死亡风险相关！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0ea41336883a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032658, encodeId=aa492032658c9, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=Neurology：体重指数对症状性颈动脉狭窄患者血运重建后的预后有啥影响？, objectType=article, longId=97316, objectId=8a079e31613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a079e31613, replyNumber=0, likeNumber=67, createdTime=2017-07-23, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a079e31613, moduleTitle=Neurology：体重指数对症状性颈动脉狭窄患者血运重建后的预后有啥影响？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8a079e31613)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032659, encodeId=bb0f20326594e, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=Stroke：无症状性颈动脉狭窄患者颈动脉支架成形术与动脉内膜切除术如何选择？, objectType=article, longId=104819, objectId=6ca310481915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ca310481915, replyNumber=0, likeNumber=68, createdTime=2017-09-11, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ca310481915, moduleTitle=Stroke：无症状性颈动脉狭窄患者颈动脉支架成形术与动脉内膜切除术如何选择？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6ca310481915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032657, encodeId=eab0203265e7b, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=NEJM：无症状性颈动脉狭窄：支架不劣于动脉内膜切除术, objectType=article, longId=63405, objectId=c889634054d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c889634054d, replyNumber=0, likeNumber=77, createdTime=2016-04-18, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c889634054d, moduleTitle=NEJM：无症状性颈动脉狭窄：支架不劣于动脉内膜切除术, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c889634054d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032656, encodeId=817720326563b, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=Atherosclerosis：超敏C反应蛋白升高与无症状性颈动脉狭窄相关, objectType=article, longId=62149, objectId=873c62149a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=873c62149a3, replyNumber=0, likeNumber=64, createdTime=2016-06-18, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=873c62149a3, moduleTitle=Atherosclerosis：超敏C反应蛋白升高与无症状性颈动脉狭窄相关, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=873c62149a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2032655, encodeId=419c203265520, content=<a href='/topic/show?id=d135e11031c' target=_blank style='color:#2F92EE;'>#症状性颈动脉狭窄#</a>, objectTitle=Stroke：抗血小板药物和降压药物能降低无症状性颈动脉狭窄患者的卒中风险, objectType=article, longId=13720, objectId=424d13e20e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=424d13e20e4, replyNumber=0, likeNumber=88, createdTime=2013-05-02, rootId=0, userName=echonoir, userId=5ed3112, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=424d13e20e4, moduleTitle=Stroke：抗血小板药物和降压药物能降低无症状性颈动脉狭窄患者的卒中风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=424d13e20e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

症状性颈动脉狭窄

2020-05-29

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

Stroke：症状性颈动脉狭窄患者血小板粘附抑制剂Revacept的疗效

2022-06-29

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

Stroke：颈动脉内膜切除术治疗症状性颈动脉狭窄不同分流模式的结局差异

2022-04-04

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

Stroke：症状性颈动脉狭窄，颈动脉内膜切除术仍然是早期治疗更安全的血管重建方法！

2021-12-27

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

ATVB：软骨寡聚基质蛋白新表位是症状性颈动脉狭窄的新型生物标志物

2021-06-28

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

JAHA：症状性颈动脉狭窄颈动脉支架置入时机与卒中或死亡风险相关！

2018-08-07

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

Neurology：体重指数对症状性颈动脉狭窄患者血运重建后的预后有啥影响？

2017-07-23

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

Stroke：无症状性颈动脉狭窄患者颈动脉支架成形术与动脉内膜切除术如何选择？

2017-09-11

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

NEJM：无症状性颈动脉狭窄：支架不劣于动脉内膜切除术

2016-04-18

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

Atherosclerosis：超敏C反应蛋白升高与无症状性颈动脉狭窄相关

2016-06-18

echonoir (审核中...)

前往app查看评论内容

#症状性颈动脉狭窄#

Stroke：抗血小板药物和降压药物能降低无症状性颈动脉狭窄患者的卒中风险

2013-05-02

科室
- - 订阅+
  - 更多科室
工具
服务